last update: Q2 2023
Licensing Opportunities
last update: Q2 2023
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Ampoules
0.02 mg/ml (5 ml)
Available
|
|
||
| Ampoules | 0.02 mg/ml (5 ml) | Available |
|
| Indications: Cutaneous T-Cell Lymphoma (CTCL) | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Gastro-resistant tablets
75 mg
Available
|
|
||
| Gastro-resistant tablets | 75 mg | Available |
|
|
Gastro-resistant tablets
100 mg
Available
|
|
||
| Gastro-resistant tablets | 100 mg | Available |
|
|
Gastro-resistant tablets
160 mg
Available
|
|
||
| Gastro-resistant tablets | 160 mg | Available |
|
|
Tablets
75 mg
Available
|
|
||
| Tablets | 75 mg | Available |
|
|
Tablets
100 mg
Available
|
|
||
| Tablets | 100 mg | Available |
|
| Indications: Antithrombotics | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Film-coated tablets
50 mg
Available
|
|
||
| Film-coated tablets | 50 mg | Available |
|
|
Film-coated tablets
150 mg
Available
|
|
||
| Film-coated tablets | 150 mg | Available |
|
|
Film-coated tablets
300 mg
Available
|
|
||
| Film-coated tablets | 300 mg | Available |
|
| Indications: Vitamin B1 Deficiency | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Film-coated tablets
10 mg
Available in Q1 2024
|
|
||
| Film-coated tablets | 10 mg | Available in Q1 2024 |
|
|
Film-coated tablets
25 mg
Available in Q1 2024
|
|
||
| Film-coated tablets | 25 mg | Available in Q1 2024 |
|
|
Film-coated tablets
50 mg
Available in Q1 2024
|
|
||
| Film-coated tablets | 50 mg | Available in Q1 2024 |
|
|
Film-coated tablets
75 mg
Available in Q1 2024
|
|
||
| Film-coated tablets | 75 mg | Available in Q1 2024 |
|
|
Film-coated tablets
100 mg
Available in Q1 2024
|
|
||
| Film-coated tablets | 100 mg | Available in Q1 2024 |
|
| Indications: Epilepsy | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Sublingual tablets
0.2 mg
Available
|
|
||
| Sublingual tablets | 0.2 mg | Available |
|
|
Sublingual tablets
0.4 mg
Available
|
|
||
| Sublingual tablets | 0.4 mg | Available |
|
|
Sublingual tablets
1 mg
Available
|
|
||
| Sublingual tablets | 1 mg | Available |
|
|
Sublingual tablets
2 mg
Available
|
|
||
| Sublingual tablets | 2 mg | Available |
|
|
Sublingual tablets
4 mg
Available
|
|
||
| Sublingual tablets | 4 mg | Available |
|
|
Sublingual tablets
6 mg
Available
|
|
||
| Sublingual tablets | 6 mg | Available |
|
|
Sublingual tablets
8 mg
Available
|
|
||
| Sublingual tablets | 8 mg | Available |
|
|
Sublingual tablets
12 mg
Available
|
|
||
| Sublingual tablets | 12 mg | Available |
|
|
Sublingual tablets
16 mg
Available
|
|
||
| Sublingual tablets | 16 mg | Available |
|
| Indications: Opioid Use Disorder | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Sublingual tablets
2 mg+0.5 mg
Available
|
|
||
| Sublingual tablets | 2 mg+0.5 mg | Available |
|
|
Sublingual tablets
4 mg+1 mg
Available
|
|
||
| Sublingual tablets | 4 mg+1 mg | Available |
|
|
Sublingual tablets
8 mg+2 mg
Available
|
|
||
| Sublingual tablets | 8 mg+2 mg | Available |
|
|
Sublingual tablets
1 mg+0.25 mg
Available in Q4 2023
|
|
||
| Sublingual tablets | 1 mg+0.25 mg | Available in Q4 2023 |
|
|
Sublingual tablets
12 mg+3 mg
Available in Q4 2023
|
|
||
| Sublingual tablets | 12 mg+3 mg | Available in Q4 2023 |
|
|
Sublingual tablets
16 mg+4 mg
Available in Q4 2023
|
|
||
| Sublingual tablets | 16 mg+4 mg | Available in Q4 2023 |
|
| Indications: Opioid Use Disorder | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Tablets
8 mg+12.5 mg
Available in 2024
|
|
||
| Tablets | 8 mg+12.5 mg | Available in 2024 |
|
|
Tablets
16 mg+12.5 mg
Available in 2024
|
|
||
| Tablets | 16 mg+12.5 mg | Available in 2024 |
|
|
Tablets
32 mg+12.5 mg
Available in 2024
|
|
||
| Tablets | 32 mg+12.5 mg | Available in 2024 |
|
|
Tablets
32 mg+25 mg
Available in 2024
|
|
||
| Tablets | 32 mg+25 mg | Available in 2024 |
|
| Indications: High Blood Pressure | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Solution for injection or infusion
5 mg/ml (2 ml, 5 ml, 10 ml)
Available
|
|
||
| Solution for injection or infusion | 5 mg/ml (2 ml, 5 ml, 10 ml) | Available |
|
|
Solution for injection or infusion
25 mg/ml (2 ml, 5 ml, 10 ml)
Available
|
|
||
| Solution for injection or infusion | 25 mg/ml (2 ml, 5 ml, 10 ml) | Available |
|
|
Solution for injection or infusion
5 mg/ml (5 ml, 10 ml, 20 ml)
Available
|
|
||
| Solution for injection or infusion | 5 mg/ml (5 ml, 10 ml, 20 ml) | Available |
|
|
Solution for injection or infusion
25 mg/ml (5 ml, 10 ml, 20 ml)
Available
|
|
||
| Solution for injection or infusion | 25 mg/ml (5 ml, 10 ml, 20 ml) | Available |
|
| Indications: Narcotic, Severe Pain | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Tablets
200 mg
Available
|
|
||
| Tablets | 200 mg | Available |
|
|
Tablets
400 mg
Available
|
|
||
| Tablets | 400 mg | Available |
|
|
Tablets
600 mg
Available
|
|
||
| Tablets | 600 mg | Available |
|
|
Tablets
800 mg
Available
|
|
||
| Tablets | 800 mg | Available |
|
| Indications: Epilepsy | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Film-coated tablets
1 mg
Available
|
|
||
| Film-coated tablets | 1 mg | Available |
|
|
Film-coated tablets
2 mg
Available
|
|
||
| Film-coated tablets | 2 mg | Available |
|
|
Film-coated tablets
3 mg
Available
|
|
||
| Film-coated tablets | 3 mg | Available |
|
| Indications: Insomnia | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Syrup
50 mg/ml (250 ml)
Available
|
|
||
| Syrup | 50 mg/ml (250 ml) | Available |
|
| Indications: Epilepsy | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Capsules
100 mg+20 mg
Dossier update pending
|
|
||
| Capsules | 100 mg+20 mg | Dossier update pending |
|
| Indications: Anaemia | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Capsules
66.7 mg+100 mg+0.8 mg
Available
|
|
||
| Capsules | 66.7 mg+100 mg+0.8 mg | Available |
|
| Indications: Anaemia during Pregnancy | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Capsules
50 mg+0.5 mg
Dossier update pending
|
|
||
| Capsules | 50 mg+0.5 mg | Dossier update pending |
|
| Indications: Anaemia during Pregnancy | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Film-coated tablets
20 mg
Available
|
|
||
| Film-coated tablets | 20 mg | Available |
|
|
Film-coated tablets
40 mg
Available
|
|
||
| Film-coated tablets | 40 mg | Available |
|
| Indications: Depression | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Tablets
1 mg
Available
|
|
||
| Tablets | 1 mg | Available |
|
|
Tablets
5 mg
Available
|
|
||
| Tablets | 5 mg | Available |
|
| Indications: Folic Acid Deficiency | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Solution for injection
2 mg/ml (1 ml)
Available
|
|
||
| Solution for injection | 2 mg/ml (1 ml) | Available |
|
|
Solution for injection
10 mg/ml (1 ml, 10 ml)
Available
|
|
||
| Solution for injection | 10 mg/ml (1 ml, 10 ml) | Available |
|
|
Solution for injection
20 mg/ml (1 ml)
Available
|
|
||
| Solution for injection | 20 mg/ml (1 ml) | Available |
|
|
Solution for injection
50 mg/ml (1 ml)
Available
|
|
||
| Solution for injection | 50 mg/ml (1 ml) | Available |
|
|
Film-coated tablets
1.3 mg
Available in Q3 2023
|
|
||
| Film-coated tablets | 1.3 mg | Available in Q3 2023 |
|
|
Film-coated tablets
2.6 mg
Available in Q3 2023
|
|
||
| Film-coated tablets | 2.6 mg | Available in Q3 2023 |
|
| Indications: Severe Pain | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Solution for injection
1 mg/ml (1 ml)
Available
|
|
||
| Solution for injection | 1 mg/ml (1 ml) | Available |
|
| Indications: Vitamin B12 Deficiency | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Solution for injection or infusion
10 mg/ml (2 ml, 5 ml, 10 ml)
Available
|
|
||
| Solution for injection or infusion | 10 mg/ml (2 ml, 5 ml, 10 ml) | Available |
|
|
Solution for injection or infusion
50 mg/ml (2 ml, 5 ml, 10 ml)
Available
|
|
||
| Solution for injection or infusion | 50 mg/ml (2 ml, 5 ml, 10 ml) | Available |
|
|
Solution for injection or infusion
10 mg/ml (5 ml, 10 ml, 20 ml)
Available
|
|
||
| Solution for injection or infusion | 10 mg/ml (5 ml, 10 ml, 20 ml) | Available |
|
|
Solution for injection or infusion
50 mg/ml (5 ml, 10 ml, 20 ml)
Available
|
|
||
| Solution for injection or infusion | 50 mg/ml (5 ml, 10 ml, 20 ml) | Available |
|
| Indications: Narcotic, Severe Pain | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Film-coated tablets
50 mg
Available
|
|
||
| Film-coated tablets | 50 mg | Available |
|
|
Film-coated tablets
100 mg
Available
|
|
||
| Film-coated tablets | 100 mg | Available |
|
|
Film-coated tablets
150 mg
Available
|
|
||
| Film-coated tablets | 150 mg | Available |
|
|
Film-coated tablets
200 mg
Available
|
|
||
| Film-coated tablets | 200 mg | Available |
|
|
Oral solution
10 mg/ml (200 ml, 500 ml)
Available
|
|
||
| Oral solution | 10 mg/ml (200 ml, 500 ml) | Available |
|
|
Solution for infusion
10 mg/ml (10 ml, 20 ml)
Available
|
|
||
| Solution for infusion | 10 mg/ml (10 ml, 20 ml) | Available |
|
|
Solution for infusion
10 mg/ml (20 ml)
Available
|
|
||
| Solution for infusion | 10 mg/ml (20 ml) | Available |
|
| Indications: Epilepsy | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Oral solution
100 mg/ml (150 ml, 300 ml)
Available
|
|
||
| Oral solution | 100 mg/ml (150 ml, 300 ml) | Available |
|
|
Concentration for solution for infusion
100 mg/ml (5 ml)
Available
|
|
||
| Concentration for solution for infusion | 100 mg/ml (5 ml) | Available |
|
| Indications: Epilepsy | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Tablets
2.5 mg
Available
|
|
||
| Tablets | 2.5 mg | Available |
|
|
Tablets
5 mg
Available
|
|
||
| Tablets | 5 mg | Available |
|
|
Tablets
10 mg
Available
|
|
||
| Tablets | 10 mg | Available |
|
|
Tablets
20 mg
Available
|
|
||
| Tablets | 20 mg | Available |
|
|
Tablets
30 mg
Available
|
|
||
| Tablets | 30 mg | Available |
|
|
Concentration for oral solution
5 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000ml)
Available
|
|
||
| Concentration for oral solution | 5 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000ml) | Available |
|
| Indications: Opioid Use Disorder | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Solution for injection
500 mg/ml (2 ml, 5 ml)
Available
|
|
||
| Solution for injection | 500 mg/ml (2 ml, 5 ml) | Available |
|
|
Film-coated tablets
500 mg
Available in 2024
|
|
||
| Film-coated tablets | 500 mg | Available in 2024 |
|
|
Film-coated tablets
1000 mg
Available in 2024
|
|
||
| Film-coated tablets | 1000 mg | Available in 2024 |
|
| Indications: Mild to Moderate Pain | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Tablets
5 mg
Available
|
|
||
| Tablets | 5 mg | Available |
|
|
Tablets
10 mg
Available
|
|
||
| Tablets | 10 mg | Available |
|
|
Tablets
20 mg
Available
|
|
||
| Tablets | 20 mg | Available |
|
|
Tablets
40 mg
Available
|
|
||
| Tablets | 40 mg | Available |
|
|
Tablets
60 mg
Available
|
|
||
| Tablets | 60 mg | Available |
|
|
Concentration for oral solution
10 mg/ml (100 ml, 150 ml,
300 ml, 500 ml, 1000 ml) Available
|
|
||
| Concentration for oral solution | 10 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000 ml) |
Available |
|
| Indications: Opioid Use Disorder | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Oral solution
1 mg/ml (150 ml)
Available
|
|
||
| Oral solution | 1 mg/ml (150 ml) | Available |
|
|
Solution for injection or infusion
5 mg/ml (2 ml, 10 ml)
Available
|
|
||
| Solution for injection or infusion | 5 mg/ml (2 ml, 10 ml) | Available |
|
| Indications: Emesis, Nausea | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Solution for injection
10 mg/ml (1 ml)
Available
|
|
||
| Solution for injection | 10 mg/ml (1 ml) | Available |
|
|
Solution for injection
10 mg/ml (10 ml)
Available
|
|
||
| Solution for injection | 10 mg/ml (10 ml) | Available |
|
|
Solution for injection
20 mg/ml (10 ml)
Available
|
|
||
| Solution for injection | 20 mg/ml (10 ml) | Available |
|
| Indications: Severe Pain | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Film-coated tablets
5 mg
Available
|
|
||
| Film-coated tablets | 5 mg | Available |
|
|
Film-coated tablets
10 mg
Available
|
|
||
| Film-coated tablets | 10 mg | Available |
|
|
Film-coated tablets
20 mg
Available
|
|
||
| Film-coated tablets | 20 mg | Available |
|
|
Prolonged-release tablets
5 mg
Available
|
|
||
| Prolonged-release tablets | 5 mg | Available |
|
|
Prolonged-release tablets
10 mg
Available
|
|
||
| Prolonged-release tablets | 10 mg | Available |
|
|
Prolonged-release tablets
15 mg
Available
|
|
||
| Prolonged-release tablets | 15 mg | Available |
|
|
Prolonged-release tablets
20 mg
Available
|
|
||
| Prolonged-release tablets | 20 mg | Available |
|
|
Prolonged-release tablets
30 mg
Available
|
|
||
| Prolonged-release tablets | 30 mg | Available |
|
|
Prolonged-release tablets
40 mg
Available
|
|
||
| Prolonged-release tablets | 40 mg | Available |
|
|
Prolonged-release tablets
60 mg
Available
|
|
||
| Prolonged-release tablets | 60 mg | Available |
|
|
Prolonged-release tablets
80 mg
Available
|
|
||
| Prolonged-release tablets | 80 mg | Available |
|
|
Oral solution
1 mg/ml (100 ml, 250 ml, 300 ml)
Available
|
|
||
| Oral solution | 1 mg/ml (100 ml, 250 ml, 300 ml) | Available |
|
|
Oral solution
10 mg/ml (30 ml, 100 ml, 120 ml)
Available
|
|
||
| Oral solution | 10 mg/ml (30 ml, 100 ml, 120 ml) | Available |
|
|
Solution for injection or infusion
10 mg/ml (1 ml, 2 ml)
Available
|
|
||
| Solution for injection or infusion | 10 mg/ml (1 ml, 2 ml) | Available |
|
| Indications: Severe Pain | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Prolonged-release tablets
5 mg+2.5 mg
Available
|
|
||
| Prolonged-release tablets | 5 mg+2.5 mg | Available |
|
|
Prolonged-release tablets
10 mg+5 mg
Available
|
|
||
| Prolonged-release tablets | 10 mg+5 mg | Available |
|
|
Prolonged-release tablets
20 mg+10 mg
Available
|
|
||
| Prolonged-release tablets | 20 mg+10 mg | Available |
|
|
Prolonged-release tablets
30 mg+15 mg
Available
|
|
||
| Prolonged-release tablets | 30 mg+15 mg | Available |
|
|
Prolonged-release tablets
40 mg+20 mg
Available
|
|
||
| Prolonged-release tablets | 40 mg+20 mg | Available |
|
| Indications: Severe Pain | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Film-coated tablets
2 mg
Available
|
|
||
| Film-coated tablets | 2 mg | Available |
|
|
Film-coated tablets
4 mg
Available
|
|
||
| Film-coated tablets | 4 mg | Available |
|
|
Film-coated tablets
6 mg
Available
|
|
||
| Film-coated tablets | 6 mg | Available |
|
|
Film-coated tablets
8 mg
Available
|
|
||
| Film-coated tablets | 8 mg | Available |
|
|
Film-coated tablets
10 mg
Available
|
|
||
| Film-coated tablets | 10 mg | Available |
|
|
Film-coated tablets
12 mg
Available
|
|
||
| Film-coated tablets | 12 mg | Available |
|
| Indications: Epilepsy | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Tablets
65 mg
Available
|
|
||
| Tablets | 65 mg | Available |
|
| Indications: Radiation Prophylaxis | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Film-coated tablets
25 mg
Available
|
|
||
| Film-coated tablets | 25 mg | Available |
|
|
Film-coated tablets
50 mg
Available
|
|
||
| Film-coated tablets | 50 mg | Available |
|
|
Film-coated tablets
75 mg
Available
|
|
||
| Film-coated tablets | 75 mg | Available |
|
|
Film-coated tablets
100 mg
Available
|
|
||
| Film-coated tablets | 100 mg | Available |
|
|
Oral solution
20 mg/ml (100 ml, 200 ml)
Available
|
|
||
| Oral solution | 20 mg/ml (100 ml, 200 ml) | Available |
|
|
Prolonged-release tablets
25 mg
Available
|
|
||
| Prolonged-release tablets | 25 mg | Available |
|
|
Prolonged-release tablets
50 mg
Available
|
|
||
| Prolonged-release tablets | 50 mg | Available |
|
|
Prolonged-release tablets
100 mg
Available
|
|
||
| Prolonged-release tablets | 100 mg | Available |
|
|
Prolonged-release tablets
150 mg
Available
|
|
||
| Prolonged-release tablets | 150 mg | Available |
|
|
Prolonged-release tablets
200 mg
Available
|
|
||
| Prolonged-release tablets | 200 mg | Available |
|
|
Prolonged-release tablets
250 mg
Available
|
|
||
| Prolonged-release tablets | 250 mg | Available |
|
| Indications: Severe Pain | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Tablets
2 mg
Available
|
|
||
| Tablets | 2 mg | Available |
|
|
Tablets
4 mg
Available
|
|
||
| Tablets | 4 mg | Available |
|
|
Tablets
6 mg
Available
|
|
||
| Tablets | 6 mg | Available |
|
| Indications: Muscle Spasms | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Solution for injection
50 mg/ml (2 ml)
Dossier update pending
|
|
||
| Solution for injection | 50 mg/ml (2 ml) | Dossier update pending |
|
|
Oral drops
100 mg/ml (10 ml, 30 ml, 50 ml)
Dossier update pending
|
|
||
| Oral drops | 100 mg/ml (10 ml, 30 ml, 50 ml) | Dossier update pending |
|
| Indications: Moderate to Severe Pain | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Oral solution
10 mg/ml (120 ml)
Available
|
|
||
| Oral solution | 10 mg/ml (120 ml) | Available |
|
|
Prolonged-release tablets
75 mg
Available in 2025
|
|
||
| Prolonged-release tablets | 75 mg | Available in 2025 |
|
|
Prolonged-release tablets
150 mg
Available in 2025
|
|
||
| Prolonged-release tablets | 150 mg | Available in 2025 |
|
| Indications: Depression | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Oral solution
300 mg/ml (100 ml)
Available
|
|
||
| Oral solution | 300 mg/ml (100 ml) | Available |
|
|
Gastro-resistant soft capsules
150 mg
Dossier update pending
|
|
||
| Gastro-resistant soft capsules | 150 mg | Dossier update pending |
|
|
Gastro-resistant soft capsules
300 mg
Dossier update pending
|
|
||
| Gastro-resistant soft capsules | 300 mg | Dossier update pending |
|
|
Gastro-resistant soft capsules
500 mg
Dossier update pending
|
|
||
| Gastro-resistant soft capsules | 500 mg | Dossier update pending |
|
|
Syrup
50 mg/ml (100 ml)
Dossier update pending
|
|
||
| Syrup | 50 mg/ml (100 ml) | Dossier update pending |
|
|
Solution for injection
100 mg/ml (5 ml)
Dossier update pending
|
|
||
| Solution for injection | 100 mg/ml (5 ml) | Dossier update pending |
|
| Indications: Epilepsy | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Film-coated tablets
100 mg+100 mg
Available
|
|
||
| Film-coated tablets | 100 mg+100 mg | Available |
|
| Indications: Vitamin B Deficiency | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Film-coated tablets
40 mg+90 mg+0,25 mg
Available in Q3 2023
|
|
||
| Film-coated tablets | 40 mg+90 mg+0,25 mg | Available in Q3 2023 |
|
|
Hard capsules
40 mg+90 mg+0,25 mg
Available in Q3 2023
|
|
||
| Hard capsules | 40 mg+90 mg+0,25 mg | Available in Q3 2023 |
|
| Indications: Vitamin B Deficiency | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Film-coated tablets
100 mg+200 mg+0.2 mg
Dossier update pending
|
|
||
| Film-coated tablets | 100 mg+200 mg+0.2 mg | Dossier update pending |
|
|
Solution for injection
50 mg+50 mg+0.5 mg/ml (2 ml)
Dossier update pending
|
|
||
| Solution for injection | 50 mg+50 mg+0.5 mg/ml (2 ml) | Dossier update pending |
|
| Indications: Neuropathic Pain, Vitamin B Deficiency | |||
| Dosage form | Dosage | Status | Appearance |
| Dosage form / Dosage | Appearance | ||
|
Oral solution
14 400 IU/ml (12.5 ml, 30 ml)
Available
|
|
||
| Oral solution | 14 400 IU/ml (12.5 ml, 30 ml) | Available |
|
|
Oral solution
28 800 IU/ml (12.5 ml, 30 ml, 50 ml)
Available
|
|
||
| Oral solution | 28 800 IU/ml (12.5 ml, 30 ml, 50 ml) | Available |
|
| Indications: Vitamin D3 Deficiency | |||
Please be advised that information on this list is subject to change. For markets with special requirements please check availability with our licensing managers.
